Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Parallel-group Trial of Topical Pimecrolimus Cream 1% (Elidel®) Versus Clobetasol 0.05% Cream for the Treatment of Vulvar Lichen Sclerosus

NCT00393263 is registered in ClinicalTrials.gov with Center for Vulvovaginal Disorders as lead sponsor.

NCT NCT00393263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00393263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Parallel-group Trial of Topical Pimecrolimus Cream 1% (Elidel®) Versus Clobetasol 0.05% Cream for the Treatment of Vulvar Lichen Sclerosus
Lead sponsor
Center for Vulvovaginal Disorders
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2006
Completion date
October 31, 2009
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lichen sclerosus